I make a donation

ADMIRAL

National multicentric trial aiming to evaluate the impact of Abciximab versus placebo in patients with an acute coronary syndrome with ST segment elevation and treated with angioplasty

Terminée

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

Bourses ACTION & PHRA 2022

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Prix de Recherche Pr Jean-Philippe COLLET

objectif

Impact of Abciximab versus placebo in patients with an acute coronary syndrome with ST segment elevation and treated with angioplasty

date de réalisation

1999

nombre de patients

300

nombre de centres participants

26 French centers

type de financement

Private (Lilly)

Publications

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
G Montalescot, P Barragan, O Wittenberg, P Ecollan, S Elhadad, P Villain, J M Boulenc, M C Morice, L Maillard, M Pansiéri, R Choussat, P Pinton, ADMIRAL Investigators
Publicated in The New England Journal of Medecine
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention
J P Collet, G Montalescot, C Lesty, Z Mishal, J Soria, R Choussat, G Drobinski, C Soria, P Pinton, P Barragan, D Thomas
Publicated in Circulation

Autres études

AFIJI

En cours

Impact of genetics on occuring of coronary diseases in young patients and the pharmacogenetic of clopidogrel and its impact on the prognosis of patients having had angioplasty

ABYSS

En cours

Phase 4 trial, evaluating the interest of betablocking treatment in the long term treatment of non-complicated myocardial infarct.

ARAMIS

En cours

Evaluation of Anakinra versus placebo in treatment of acute myocarditis and evaluation of the contuity of the reference treatment with IEC in patients without ventricular dysfunction ventriculaire.